Infinitum Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Infinitum Asset Management’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-155,529	Closed	-$701K	–	32
2025 Q2	$701K	Hold	155,529	–	–	0.16%	26
2025 Q1	$689K	Hold	155,529	–	–	0.22%	24
2024 Q4	$1.22M	Buy	+155,529	New	+$1.89M	0.64%	16

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Infinitum Asset Management's YMAB Position: Q3 2025 in Review

Infinitum Asset Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 155,529 shares — an estimated $701K sold.

Infinitum Asset Management first reported a position in YMAB in Q4 2024 and held it in 3 quarters. The position peaked at $1.22M in Q4 2024. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

Infinitum Asset Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
Infinitum Asset Management sold 155,529 Y-mAbs Therapeutics shares in Q3 2025, an estimated $701K.
Infinitum Asset Management first reported a position in Y-mAbs Therapeutics in Q4 2024 and held it in 3 quarters.
Infinitum Asset Management's Y-mAbs Therapeutics position peaked at $1.22M in Q4 2024.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Infinitum Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.